CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Best Funds Best Places to Retire Fortune Brainstorm Tech Apple 2.0 Blog Big Tech Blog Sectors and Stocks Tech Talk Resource Guide Small Business Makeovers Questions & Answers Small Business Video 100 Best Places to Launch FSB 100 Fortune Small Business Fortune 500 Brainstorm Tech Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts
More Galleries
Better digs, less money These 6 businesses took advantage of crashed real estate prices to trade up for new stores and office space. More
The no-cash economy Beer, lingerie, ad space and high-end electronics were some of the offerings business owners put up for swap at this week's Barter Business Unlimited holiday trade show. More
Black diamonds A North Carolina entrepreneur wants America to fall in love with truffles. More

Special Offer
8 of 36
BACK NEXT
Taking the sting out of canker sores
Taking the sting out of canker sores
Stephen Patterson, Patrick Gosselin, Matt Cara and Stephanie Bowen
•  enexra  video
Team name: AiB Pharma

School name: Texas A&M University, Mays Business School

Team members: Patrick Gosselin, Stephen Patterson, Matt Cara, Stephanie Bowen

Concept: Canker sores might hurt a little, but they hurt a lot of people. By one estimate, the tiny mouth ulcers make 20% of the population miserable. So far, no one has figured out what causes them or how to cure them. Available products that claim to reduce the pain and duration of the sores are often so nasty that about 80% of afflicted people choose to grimace and bear the pain without attempting treatment.

The members of AiB Pharma believe a chemical cocktail invented by Dr. Phil Campbell (who serves as an advisor to the company), a professor at the Baylor College of Dentistry, can soothe millions of mouths and make this early-stage pharmaceutical company millions of dollars. A double blind study at Baylor showed the product's efficacy to be "statistically significant," while 14 private practice dentists used the formula on more than 2,000 patients with "enormous success." The company claims the drug speeds healing by up to 86%.

Timeline: The founders of AiB Pharma believe they can have a product on the market in about four years. - Shara Rutberg

NEXT: A nanotherapy for liver cancer

Last updated May 02 2008: 11:51 AM ET
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.